COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,738 Articles (22,502 medRxiv, 8,236 bioRxiv)

Most recent first Previous |  Page 1348: Articles 13471-13480  | Next

Informing University COVID-19 Decisions Using Simple Compartmental Models
Hurt, B., Adiga, A., Marathe, M., Barrett, C.
10.1101/2021.07.01.21259851 — Posted: 2021-07-06
Modeling the COVID-19 Vaccination Dynamics in the United States: An Estimation of Coverage Velocity and Carrying Capacity Based on Socio-demographic Vulnerability Indices in California
Bruckhaus, A., Abedi, A., Salehi, S., Pickering, T. A., Zhang, Y., Martinez, A., Lai, M., Garner, R., Duncan, D.
10.1101/2021.07.03.21259881 — Posted: 2021-07-06
COVID-19 Vaccination acceptance in the canton of Geneva: A Cross-Sectional Population-Based Study
Wisniak, A., Baysson, H., Pullen, N., Nehme, M., Pennacchio, F., Zaballa, M.-E., Guessous, I., Stringhini, S., Specchio-COVID19 study group
10.1101/2021.07.05.21260024 — Posted: 2021-07-06
Attitudes towards a mandatory COVID-19 vaccination in France for the general population or healthcare workers in May 2021
Gagneux-Brunon, A., Botelho-Nevers, e., Bonneton, M., Peretti-Watel, P., Verger, P., Launay, O., Ward, J. K.
10.1101/2021.07.05.21260017 — Posted: 2021-07-06
Genomic Surveillance of SARS-CoV-2 in Erie County, New York
Lamb, N. A., Bard, J. E., Pohlman, A., Boccolucci, A., Yergeau, D. A., Marzullo, B. J., Pope, C., Burstein, G. R., Tomaszewski, J., Surtees, J. A.
10.1101/2021.07.01.21259869 — Posted: 2021-07-06
Safety and Pharmacokinetics of Intranasally Administered Heparin
Harris, H. M., Boyet, K. L., Liu, H., Dwivedi, R., Ashpole, N. M., Tandon, R., Bidwell, G. L., Pomin, V. H., Mitra, D., Harrison, K. A., Dahl, E., Gurley, B. J., Kotha, A. K., Chougule, M. B., Sharp, J. S.
10.1101/2021.07.05.21259936 — Posted: 2021-07-06
Transmission dynamics of COVID-19 in Ghana and the impact of public health interventions
Ofori, S. K., Schwind, J. S., Sullivan, K. L., Cowling, B. J., Chowell, G., Fung, I. C.-H.
10.1101/2021.07.04.21259991 — Posted: 2021-07-06
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: a population-based register study with implications to vaccinations
Salo, H., Lehtonen, T., Auranen, K., Baum, U., Leino, T.
10.1101/2021.07.04.21259954 — Posted: 2021-07-06
Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
Duerr, R., Dimartino, D., Marier, C., Zappile, P., Wang, G., Lighter, J., Elbel, B., Troxel, A., Heguy, A.
10.1101/2021.07.05.21259547 — Posted: 2021-07-06
Whole-genome sequencing of SARS-COV-2 reveals a substantially lower frequency of the UK variant than previously announced in Libya
Alhudiri, I. M., Ramadan, A. M., Ibrahim, K. I., Eljilani, M., Aboud, A. A., Salem, M. A., Elgheriani, H. M., Elzagheid, A.
10.1101/2021.07.03.21257942 — Posted: 2021-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).